Status:
RECRUITING
Evaluation of Advanced Practice Nurse's Management of Patients with Chronic Myeloid Leukemia
Lead Sponsor:
Centre Hospitalier Henri Duffaut - Avignon
Conditions:
Chronic Myelogenous Leukemia - Chronic Phase
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic Myeloid Leukemia (CML) affects 820 people per year in France (2018), half of them are older than 60 years old. Tyrosine Kinase Inhibitors (TKI) are new kind of targeted therapy whose efficien...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old.
- CML patient in chronic phase, eligible for oral therapy.
- Newly diagnosed CML and/or initiating oral therapy :
- Patient changing treatment for non-response or loss of therapeutic response or toxicities, on the condition that these toxicities are resolved or grade I maximum at the time of inclusion.
- Newly start of oral therapy.
- Patient eligible to a follow-up by an advanced practice nurse.
- Patient capable to understand french and complete a questionnaire.
Exclusion
- Patient that had a follow-up \> 3 months by an advanced practice nurse for CML before inclusion.
- Patient changing treatment for toxicities, if these toxicities are still \> grade I at inclusion.
- Patient enrolled in another interventional research protocol for CML.
- Pregnant women.
- Patient under legal protection, deprived of liberty or unable to be included in a research protocol.
Key Trial Info
Start Date :
November 29 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06082804
Start Date
November 29 2023
End Date
December 1 2027
Last Update
January 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Avignon, France